Peptide Vault Labs
≥99% Purity
Made in the USA
Research Use Only
Third-Party Batch Tested
Research Library
Growth Hormone SignalingIGF-1 LR3 research vial

Peptide Vault Labs Education

IGF-1 LR3

Also known as Long R3 IGF-1, Long Arg3 IGF-I

Primary research target

Modified IGF-1 analog investigated in receptor signaling, cell growth, protein synthesis, and prolonged IGF-binding-protein resistance.

Research category

Growth Hormone Signaling

GHRH analogs, ghrelin-receptor agonists, secretagogues, and related endocrine research materials.

Educational research information only

This profile describes areas of scientific interest. It does not provide medical advice, dosing, reconstitution, administration, treatment, or human-use instructions.

Browse research catalog

Compound

IGF-1 LR3

Research category

Growth Hormone Signaling

Information type

Educational overview

Common names and aliases

Long R3 IGF-1Long Arg3 IGF-I

Catalog references

  • IGF-1 LR3

Related research

Explore similar compounds

View full library

CJC-1295 No DAC

GHRH-receptor agonist research focused on pulsatile growth-hormone signaling and endocrine pharmacology.

View profile
Ipamorelin research vial

Ipamorelin

Selective ghrelin-receptor agonist investigated in growth-hormone secretion and endocrine signaling research.

View profile
Tesamorelin research vial

Tesamorelin

Stabilized GHRH analog with established clinical and regulatory literature involving growth-hormone-axis pharmacology.

View profile
Hexarelin research vial

Hexarelin

Potent ghrelin-receptor agonist investigated in growth-hormone secretion and cardiovascular and endocrine models.

View profile

Educational and laboratory research information only

The Peptide Vault Labs Research Library is provided solely for educational, analytical, and laboratory research reference. Content does not diagnose, treat, cure, or prevent disease and must not be interpreted as prescribing, dosing, administration, reconstitution-for-use, or patient-care guidance. Experimental findings—especially animal, cell, and in vitro findings—do not establish safety or efficacy in humans. Researchers must use validated institutional protocols, applicable laws, safety data sheets, certificates of analysis, and qualified laboratory oversight.